Details for 2010713516
Up to date per 01.04.2026
Actions
Details for 2010713516
Granted/Registered
European Patent
01.02.2012 A
06.05.2020 B1
24.03.2009
US
162999 P
A61K 39/095 20060101AFI20101014BHEP
Owner
GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
CONTORNI, MarioNovartis Vaccines Via Fiorentina 1 I-53100 SienaIT
TARLI, LorenzoNovartis Vaccines Via Fiorentina 1 I-53100 SienaIT
Information about Fees